Budesonide showed no clear difference in serious adverse events compared with mesalamine (low certainty).
Budesonide showed no clear difference in serious adverse events compared with mesalazine (low certainty).
It is very uncertain whether budesonide changes serious adverse events compared with placebo (very low certainty).
Budesonide MMX® 6 mg showed no clear difference in serious adverse events compared with placebo (low certainty).
Budesonide MMX® 9 mg showed no clear difference in serious adverse events compared with entocort EC 9mg (low certainty).
Budesonide MMX® 9 mg showed no clear difference in serious adverse events compared with placebo (low certainty).
Budesonide/formoterol (BDF) showed no clear difference in adverse events—'serious'—320/94 Duration of 10 months3 compared with placebo (low certainty).
Budesonide/formoterol (BDF) showed no clear difference in adverse events—'serious'—160/94 Duration of nine months 3 compared with placebo (low certainty).